Prof. Dr. Fatih Demirkan
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Leukemia, Lymphocytic, Chronic, B-Cell 11 publicationsSource: OpenAlex / PubMed MeSHView publications
- Multiple Myeloma 9 publications
- COVID-19 8 publications
- Lymphoma, Large B-Cell, Diffuse 5 publications
- Leukemia, Myeloid, Acute 4 publications
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 publications
- Leukemia, Hairy Cell 2 publications
- Liver Cirrhosis 2 publications
- Lymphoma, Non-Hodgkin 2 publications
- Lymphoma 2 publications
- Myelodysplastic Syndromes 2 publications
- Thrombosis 2 publications
- Hypertension 2 publications
- Kidney Failure, Chronic 2 publications
- Pre-Eclampsia 2 publications
- Hypothyroidism 2 publications
- Behcet Syndrome 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyHaematologymemorial.com.trFrom source
- InstitutionMemorial Antalya Hastanesimemorial.com.trFrom source
- Area of workLeukemia, Lymphocytic, Chronic, B-CellExtracted from 11 publications · Model version —From source
- Publications204 publicationsORCID, Europe PMC, OpenAlexFrom source
- ORCID0000-0002-1172-8668ORCIDFrom source
- Last synchronised5 November 2026 06:02https://www.memorial.com.tr/doktorlar/fatih-demirkanmemorial.com.tr
Scientific work
Publications on Leukemia, Lymphocytic, Chronic, B-Cell
-
Thrombotic Events and Overall Survival in BCR-ABL1 Negative Myeloproliferative Neoplasms: A Single-Center Analysis
Konuralp Tip Dergisi, 2026
DOI 10.18521/ktd.1838654 Open-access full textSource: ORCID
-
Prognostic Significance of Paraproteinemia in Marginal Zone Lymphoma
Turkish journal of haematology : official journal of Turkish Society of Haematology, 2026
DOI 10.4274/tjh.galenos.2025.2025.0174 PMID 40891517 Open-access full textSource: Europe PMC
-
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18–65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network
The Lancet, 2026
DOI 10.1016/s0140-6736(26)00362-4 PMID 42134356 11 citations (OpenAlex) Open-access full textSource: OpenAlex
-
Molecular Characterization of RhD Variants in the Turkish Population: A Multicenter Study for Population-Specific Diagnostic Strategy Development
Research Square, 2026
DOI 10.21203/rs.3.rs-8630300/v1 Open-access full textSource: OpenAlex
-
Refractory Thrombocytopenia in TP53—Aberrant Chronic Lymphocytic Leukemia: A Multimechanistic Case with Response to Idelalisib and Romiplostim
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15124483 PMID 42355651 Open-access full textSource: OpenAlex
-
Clinical Characteristics, Treatment Approaches, and Survival Predictors in Adult Acute Myeloid Leukemia: Interim Results from the Turkish Society of Hematology AML Registry
Journal of Clinical Medicine, 2025
DOI 10.3390/jcm14207367 PMID 41156238 Open-access full textSource: OpenAlex
-
AML-556: Personalized Therapy and Real-World Outcomes in Adult Acute Myeloid Leukemia: Lessons From a Nationwide Prospective Cohort in Turkey
Clinical Lymphoma Myeloma & Leukemia, 2025
DOI 10.1016/s2152-2650(25)01691-x Source: OpenAlex
-
POSTER: AML-556 Personalized Therapy and Real-World Outcomes in Adult Acute Myeloid Leukemia: Lessons From a Nationwide Prospective Cohort in Turkey
Clinical Lymphoma Myeloma & Leukemia, 2025
DOI 10.1016/s2152-2650(25)00540-3 Source: OpenAlex
-
Therapeutic Plasma Exchange Experience in Internal Medicine Clinics: a Retrospective Review of 1,048 Procedures
SN Comprehensive Clinical Medicine, 2025
DOI 10.1007/s42399-025-02228-0 Open-access full textSource: ORCID
-
The Contributions of Turkish Hematology to the Global Literature: A Comparative Analysis
Turkish journal of haematology : official journal of Turkish Society of Haematology, 2025
DOI 10.4274/tjh.galenos.2025.2025.0029 PMID 40353344 Open-access full textSource: Europe PMC